Lombard Medical, Inc. (EVARF)

Market Cap	28.00
Revenue (ttm)	12.17M -19.5%
Net Income	-31.04M
EPS	-1.54
Shares Out	27.95M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,711
Open	0.000001
Previous Close	0.000001
Day's Range	0.000001 - 0.000001
52-Week Range	0.000001 - 0.000001
Beta	0.91
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Lombard Medical

Lombard Medical, Inc., a medical technology company, develops, manufactures, and markets endovascular stent-grafts for the repair of aortic aneurysms in the United States, the United Kingdom, Germany, Japan, and internationally. Its principal product is Aorfix, which is an endovascular stent-graft for the treatment of abdominal aortic aneurysms (AAAs) with angulation at the neck of the aneurysm of up to 90 degrees. The company’s products also include Altura endovascular stent graft system for the treatment of standard AAA anatomies; Aorflex del...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1994
• Employees: 113
• Stock Exchange: OTCMKTS
• Ticker Symbol: EVARF

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 14, 2026

Data Sources Report a data error